Search Results - "MOORE, L. MERKLE"

A new animal model of insulin-glucose dynamics in the intraperitoneal space enhances closed-loop control performance by Chakrabarty, Ankush, Gregory, Justin M., Moore, L. Merkle, Williams, Philip E., Farmer, Ben, Cherrington, Alan D., Lord, Peter, Shelton, Brian, Cohen, Don, Zisser, Howard C., Doyle, Francis J., Dassau, Eyal

“…•State-of-the-art control algorithms delivering insulin subcutaneously (SC) to treat type 1 diabetes (T1D) exhibit slow diffusion and lag.•Alternative insulin…”
Get full text

Case Report: Syndrome of Remitting Seronegative Symmetrical Synovitis with Pitting Edema—A Rare but Treatable Condition in Palliative Medicine by Moore, L Merkle, Brouner, Jennifer M, Grigorian, Nelly, Leach, R J, Baumrucker, Steven J

“…The syndrome of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) is a rare diagnosis that is often missed due to lack of both definitive…”
Get full text

The kinetics of glucagon action on the liver during insulin-induced hypoglycemia by Pedersen, Christina, Kraft, Guillaume, Edgerton, Dale S, Scott, Melanie, Farmer, Ben, Smith, Marta, Laneve, David C, Williams, Phillip E, Moore, L Merkle, Cherrington, Alan D

“…Glucagon's effect on hepatic glucose production (HGP), under hyperglycemic conditions, is time dependent such that after an initial burst of HGP, it slowly…”
Get more information

1801-P: Common Hepatic Artery Denervation Does Not Alter the Counterregulatory Response to Hypoglycemia in an Insulin Resistant Canine Model by KRAFT, GUILLAUME, MOORE, L. MERKLE, FARMER, BEN, SCOTT, MELANIE F., EDGERTON, DALE S., WILLIAMS, PHILLIP E., AZAMIAN, BOBAK, CHERRINGTON, ALAN D.

“…With the recent interest in sympathetic modulation as a way to improve insulin sensitivity and insulin secretion, it is important to assess the safety of the…”
Get full text

Enterically delivered insulin tregopil exhibits rapid absorption characteristics and a pharmacodynamic effect similar to human insulin in conscious dogs by Gregory, Justin M., Lautz, Margaret, Moore, Lindsey M., Williams, Phillip E., Reddy, Praveen, Cherrington, Alan D.

“…Aims Current therapy fails to emulate rapid (first‐phase) insulin release in relation to a meal, a key defect in types 1 and 2 diabetes. We aimed to quantify…”
Get full text

Incretin Hormone Release Does Not Involve Hepatic Portal Vein Glucose Sensors by EDGERTON, DALE S., KRAFT, GUILLAUME, SMITH, MARTA S., MERKLE MOORE, L., FARMER, BEN, SARA, HEATHER, SCOTT, MELANIE, MOORE, MARY, NAUCK, MICHAEL A., CHERRINGTON, ALAN D.

“…The incretin effect, which is defective in individuals with T2D, involves the secretion of GLP-1 and GIP when glucose is given orally, but not when it is…”
Get full text

Basal Oral Insulin Analog I338 Enhances Meal-Related Hepatic Glucose Disposal by MOORE, MARY C., NISHIMURA, ERICA, BRAND, CHRISTIAN L., KJELDSEN, THOMAS, MADSEN, PETER, REFSGAARD, HANNE H., WASSERMANN, KARSTEN, GRAM-NIELSEN, SANNE, SMITH, MARTA S., MOORE, L. MERKLE, FARMER, BEN, HASTINGS, JON R., WILLIAMS, PHILLIP E., CHERRINGTON, ALAN D.

“…Oral insulin avoids the need for injections, and insulin enters via the hepatic portal vein (Po), the normal route of secretion. We examined the effect of…”
Get full text

Case Report: Syndrome of Remitting Seronegative Symmetrical Synovitis with Pitting Edema-A Rare but Treatable Condition in Palliative Medicine by Moore, L Merkle, Brouner, Jennifer M, Grigorian, Nelly, Leach, R J, Baumrucker, Steven J

Get full text